ICECURE’S PROSENSE® TUMOR FREEZING PRODUCT APPROVED FOR MARKET IN SOUTH AFRICA

Following IceCure’s accelerating global expansion, the company has received regulatory approval for the treatment of benign and cancerous tumors in many indications including for the breast, lung, bone and kidney. Through their new exclusive partner,Tecmed Africa, IceCure’s technology will lead the field in bringing cryoablation to South Africa. Read more